|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
16
|
|
pubmed:dateCreated |
2009-8-11
|
|
pubmed:abstractText |
We evaluated the efficacy of topically applied human recombinant epidermal growth factor (rhEGF) for the treatment of oral mucositis induced by radiotherapy (RT), with or without chemotherapy, in patients with head and neck cancer.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Aug
|
|
pubmed:issn |
0008-543X
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
15
|
|
pubmed:volume |
115
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
3699-708
|
|
pubmed:meshHeading |
pubmed-meshheading:19514089-Administration, Inhalation,
pubmed-meshheading:19514089-Adult,
pubmed-meshheading:19514089-Aged,
pubmed-meshheading:19514089-Combined Modality Therapy,
pubmed-meshheading:19514089-Double-Blind Method,
pubmed-meshheading:19514089-Epidermal Growth Factor,
pubmed-meshheading:19514089-Female,
pubmed-meshheading:19514089-Head and Neck Neoplasms,
pubmed-meshheading:19514089-Humans,
pubmed-meshheading:19514089-Middle Aged,
pubmed-meshheading:19514089-Placebos,
pubmed-meshheading:19514089-Radiation Injuries,
pubmed-meshheading:19514089-Recombinant Proteins,
pubmed-meshheading:19514089-Stomatitis
|
|
pubmed:year |
2009
|
|
pubmed:articleTitle |
Therapeutic effect of recombinant human epidermal growth factor (RhEGF) on mucositis in patients undergoing radiotherapy, with or without chemotherapy, for head and neck cancer: a double-blind placebo-controlled prospective phase 2 multi-institutional clinical trial.
|
|
pubmed:affiliation |
Department of Radiation Oncology and Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea.
|
|
pubmed:publicationType |
Journal Article,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study,
Clinical Trial, Phase II
|
